Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Antonio W. Zuardi"'
Autor:
Nathália Abichabki, Luísa V. Zacharias, Natália C. Moreira, Fernando Bellissimo-Rodrigues, Fernanda L. Moreira, Jhohann R. L. Benzi, Tânia M. C. Ogasawara, Joseane C. Ferreira, Camila M. Ribeiro, Fernando R. Pavan, Leonardo R. L. Pereira, Guilherme T. P. Brancini, Gilberto Ú. L. Braga, Antonio W. Zuardi, Jaime E. C. Hallak, José A. S. Crippa, Vera L. Lanchote, Rafael Cantón, Ana Lúcia C. Darini, Leonardo N. Andrade
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-15 (2022)
Abstract This study aimed to assess the ultrapure cannabidiol (CBD) antibacterial activity and to investigate the antibacterial activity of the combination CBD + polymyxin B (PB) against Gram-negative (GN) bacteria, including PB-resistant Gram-negati
Externí odkaz:
https://doaj.org/article/ae1829c578164a918ba84423fa5930b6
Autor:
José Diogo S. Souza, Antonio W. Zuardi, Francisco S. Guimarães, Flávia de Lima Osório, Sonia Regina Loureiro, Alline Cristina Campos, Jaime E. C. Hallak, Rafael G. Dos Santos, Isabella Lara Machado Silveira, Karina Pereira-Lima, Julia Cozar Pacheco, Juliana Mayumi Ushirohira, Rafael Rinaldi Ferreira, Karla Cristinne Mancini Costa, Davi Silveira Scomparin, Franciele Franco Scarante, Isabela Pires-Dos-Santos, Raphael Mechoulam, Flávio Kapczinski, Benedito A. L. Fonseca, Danillo L. A. Esposito, Maristela Haddad Andraus, José Alexandre S. Crippa
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Objective: To assess whether the effects of oral administration of 300 mg of Cannabidiol (CBD) for 28 days on mental health are maintained for a period after the medication discontinuation.Methods: This is a 3-month follow-up observational and clinic
Externí odkaz:
https://doaj.org/article/8026325a792a4f3385d5fbeeaf3dd296
Autor:
Talita A. M. Vrechi, Anderson H. F. F. Leão, Ingrid B. M. Morais, Vanessa C. Abílio, Antonio W. Zuardi, Jaime Eduardo C. Hallak, José Alexandre Crippa, Claudia Bincoletto, Rodrigo P. Ureshino, Soraya S. Smaili, Gustavo J. S. Pereira
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Abstract Autophagy is a lysosomal catabolic process essential to cell homeostasis and is related to the neuroprotection of the central nervous system. Cannabidiol (CBD) is a non-psychotropic phytocannabinoid present in Cannabis sativa. Many therapeut
Externí odkaz:
https://doaj.org/article/a46c941a43f34917aeb73fb065d339df
Autor:
Ila M.P. Linares, Antonio E. Nardi, Francisco S. Guimarães, Katia C. Arrais, Marcos H. Chagas, Flavia L. Osório, Jaime E. Hallak, Antonio W. Zuardi, Norberto C. Coimbra, José A. Crippa
Publikováno v:
Brazilian Journal of Psychiatry, Vol 43, Iss 5, Pp 477-483 (2020)
Objective: The aim of the present study was to analyze the body sway response in specific phobia (SP) patients and healthy controls while viewing neutral, phobic, and disgusting images. Methods: The participants’ heart rate (HR) and skin conductanc
Externí odkaz:
https://doaj.org/article/40905648ce534a3093bf3c35bfa0a4a8
Autor:
José Diogo S. Souza, Maíra Fassoni-Ribeiro, Rayssa Miranda Batista, Juliana Mayumi Ushirohira, Antonio W. Zuardi, Francisco S. Guimarães, Alline C. Campos, Flávia de Lima Osório, Daniel Elias, Cacilda S. Souza, AndRea A. Fassoni, Jaime E. C. Hallak, José Alexandre S. Crippa
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Cannabidiol (CBD) is a non-psychotomimetic constituent of the Cannabis plant, with potential therapeutic properties for many physical and neuropsychiatric conditions. Isolated CBD has been suggested to have favorable safety and tolerability. Although
Externí odkaz:
https://doaj.org/article/0c39068f04cb40de88ef3f0832644c05
Autor:
Carolina de Meneses-Gaya, José A. Crippa, Jaime E. Hallak, André Q. Miguel, Ronaldo Laranjeira, Rodrigo A. Bressan, Antonio W. Zuardi, Acioly L. Lacerda
Publikováno v:
Brazilian Journal of Psychiatry, Vol 43, Iss 5, Pp 467-476 (2020)
Objective: To assess the efficacy of cannabidiol (CBD) in the management of crack-cocaine craving and the treatment of frequent withdrawal symptoms. Methods: Thirty-one men with a diagnosis of crack-cocaine dependence were enrolled in a randomized, d
Externí odkaz:
https://doaj.org/article/6463509035cc495cbeb3cb7d78faaf14
Autor:
Leonardo Moscovici, Estenifer M. Balco, Natalia C. Degani, Lívia M. Bolsoni, João M.A. Marques, Antonio W. Zuardi
Publikováno v:
Brazilian Journal of Psychiatry, Vol 42, Iss 4, Pp 360-366 (2020)
Objective: To investigate associations between the percentage and severity of mental disorders (MD) and three different primary health care (PHC) strategies in Brazil: traditional care (TC), the Family Health Strategy (FHS), and FHS with shared menta
Externí odkaz:
https://doaj.org/article/88c9e7d516e3423b816699877634a476
Autor:
Ana Caroline Brambilla Falvella, Bradley Joseph Smith, Licia C. Silva-Costa, Aline G. F. Valença, Fernanda Crunfli, Antonio W. Zuardi, Jaime E. Hallak, José A. Crippa, Valéria de Almeida, Daniel Martins-de-Souza
Publikováno v:
Frontiers in Molecular Neuroscience, Vol 14 (2021)
Externí odkaz:
https://doaj.org/article/4f73b0be481f4b74ac2fdab134082d19
Autor:
José Diogo R. Souza, Julia Cozar Pacheco, Giordano Novak Rossi, Bruno O. de-Paulo, Antonio W. Zuardi, Francisco S. Guimarães, Jaime E. C. Hallak, José Alexandre Crippa, Rafael G. Dos Santos
Publikováno v:
Pharmaceutics, Vol 14, Iss 12, p 2598 (2022)
(1) Background: With the massive demand for the use and commercialization of medicinal cannabidiol (CBD) products, new randomized clinical trials (RCTs) are being published worldwide, with a constant need for safety and efficacy evaluation. (2) Metho
Externí odkaz:
https://doaj.org/article/ef11758683e14a40b61b14b1ae03c6e7
Autor:
Ana Caroline Brambilla Falvella, Bradley Joseph Smith, Licia C. Silva-Costa, Aline G. F. Valença, Fernanda Crunfli, Antonio W. Zuardi, Jaime E. Hallak, José A. Crippa, Valéria de Almeida, Daniel Martins-de-Souza
Publikováno v:
Frontiers in Molecular Neuroscience, Vol 14 (2021)
Cannabidiol, a compound of Cannabis sativa, has been proposed as an alternative treatment of schizophrenia. Preclinical and clinical data have suggested that cannabidiol shares more similarity with atypical antipsychotics than typical, both of which
Externí odkaz:
https://doaj.org/article/af142fd89ab54a98932f445147993b8b